43 results on '"Willis, Fenella"'
Search Results
2. An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom
3. RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
4. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services.
5. Optimising peripheral blood progenitor cell mobilisation
6. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis
7. Chemotherapy May Obviate Prophylactic Femoral Nail Surgery for Multiple Myeloma Patients With High Mirels’ Score Lesions and Impending Pathological Hip Fracture
8. Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper.
9. The Development of a Diagnostic Tool to Help Primary Care Clinicians Manage Patients with Suspected Myeloma
10. P-175: Identifying risk factors of monoclonal gammopathy of undetermined significance (MGUS): a population-based study using data from the UK clinical practice research datalink (CPRD)
11. Bruising and abnormal leucocytes on a blood film—a haematological emergency
12. 3223 – THE DEVELOPMENT OF A DIAGNOSTIC TOOL TO HELP PRIMARY CARE CLINICIANS MANAGE PATIENTS WITH SUSPECTED MYELOMA
13. Case report: Interference from isatuximab on serum protein electrophoresis prevented demonstration of complete remission in a myeloma patient
14. Association of Mannose-Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients
15. OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM)
16. Optimizing the management of patients with spinal myeloma disease
17. Thrombopoietic agents
18. P-094 Characterising risk and biology of smouldering myeloma for early detection of symptomatic myeloma: data from the UK cosmos study
19. Case report: Interference from isatuximab on serum protein electrophoresis prevented demonstration of complete remission in a myeloma patient.
20. First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient
21. ENDGAMES
22. Breathlessness and chest pain in a patient with sickle cell disease
23. Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study
24. Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital
25. Efficacy and Safety of Carfilzomib at 56mg/m2 with Cyclophosphamide and Dexamethasone (K56Cd) in Newly Diagnosed Multiple Myeloma Patients Followed By ASCT or K56Cd Consolidation: Initial Results of the Phase 2 Cardamon Study
26. Case study of patient receiving Clinical Hypnotherapy and Mindfulness (CHAM) Programme For A Severely Needle-Phobic Patient Requiring Bone Marrow Biopsy
27. Quality Improvement Project (QIP) - Integrated Therapies (IT) Service Development In A Busy London Teaching Hospital To Meet The Complex Biopsychosocial Needs Associated With Cancer Patients In Order To Improve The Patients’ Wellbeing And Quality Of Life (Qol)
28. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells
29. Pegfilgrastim alone successfully mobilizes peripheral CD34+ cells in chemotherapy-naïve subjects with solid tumors: initial results of a phase 1-2 study.: 106E.
30. First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient.
31. Real‐world tyrosine kinase inhibitor treatment pathways, monitoring patterns and responses in patients with chronic myeloid leukaemia in the United Kingdom: the UK TARGET CML study.
32. Elevated Tricuspid Regurgitation Jet Velocity on Echocardiogram In Patients with Sickle Cell Disease Is Associated with Worse Steady State Functional Class, Poor Lung Function and Low Haemoglobin but Not Other Markers of Haemolysis or Endothelin-1.
33. Prevalence Of Pulmonary Hypertension In Patients With Sickle Cell Disease
34. Infectious Causes of Chronic Immune Thrombocytopenia
35. Automated Erythrocytapheresis in Sickle Cell Disease: Impact On Hospital Admission Rate and Iron Loading.
36. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B‐chronic lymphocytic leukaemia cells
37. Matrix Metalloproteinase 9 Levels Are Increased in Pegfilgrastim and Filgrastim Induced Mobilisation but Do Not Predict Efficiency of Mobilisation
38. Valproate, a Histone Deacetylase Inhibitor, Enhances Purine Nucleoside Analogues Induced Apoptosis of B-Chronic Lymphocytic Leukemia Cells.
39. Pegfilgrastim Alone Successfully Mobilizes Peripheral CD34+ Cells in Chemotherapy Naive Subjects with Solid Tumors: Initial Results of a Phase 1-2 Study.
40. Pegfilgrastim
41. Efficacy and Safety of Carfilzomib at 56mg/m2with Cyclophosphamide and Dexamethasone (K56Cd) in Newly Diagnosed Multiple Myeloma Patients Followed By ASCT or K56Cd Consolidation: Initial Results of the Phase 2 Cardamon Study
42. Bruising and abnormal leucocytes on a blood film—a haematological emergency
43. Successful serial plasmapheresis for solar urticaria, a case report and literature review.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.